Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
ZVSA
$0.10
+0.00%
ZVSA · ZyVersa Therapeutics, Inc.
$0.10
+0.00 (+0.00%)
At close · Aug 17
Going-concern doubt
— flagged May 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These uncertainties raise substantial doubt about our ability to continue as a going concern for 12 months after the issuance date of our financial statements.”View the 10-Q filed May 13, 2026
Market Cap
$801,496
Shares
8.10M
All earnings calls
Earnings call · FY2024 Q3
ZyVersa Therapeutics, Inc. Q3 FY2024 Earnings Call
ZyVersa Therapeutics, Inc. Q3 FY2024 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Diluted EPS
-$2.43
Net income
-$2.40M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 14, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 14, 2024 · complete as-filed document